Amarin Corp Plc (AMRN)

[Biobillionair]

Bottom line: "The inability to obtain marketing approval in the ANCHOR or REDUCE-IT indications has and would prevent us from growing revenue significantly, and it has had, and could continue to have, a material adverse effect on our operations and financial condition, including our ability to reach profitability."